Back to Database
CJC-1295
PerformanceInvestigational
Overview
CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) with a Drug Affinity Complex (DAC) that extends its half-life. It was developed to increase GH and IGF-1 secretion while maintaining the natural pulsatile release pattern. Research focuses on its effects on body composition, recovery, and sleep quality.
Evidence Strength
🟡
Limited Human Evidence
Preliminary or limited human data available
🟢Human Clinical Evidence
🟡Limited Human Evidence
🟠Mostly Animal Research
🔴Preclinical / Laboratory
This information is for educational and research purposes only. It does not constitute medical advice. Always consult a qualified healthcare professional before making any health decisions.